CU Medical Systems Inc (115480) — Capital Reinvestment Ratio

Latest as of September 2025: 0.05x

CU Medical Systems Inc (115480) has a Capital Reinvestment Ratio of 0.05x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩3.43 Billion) in capital expenditures (₩181.68 Million). Check 115480 tangible net assets ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.05x
Capex / Operating Cash Flow

Operating Cash Flow

₩3.43 Billion
KRW

Capital Expenditures

₩181.68 Million
KRW

Data as of

Sep 2025
Most recent filing

CU Medical Systems Inc Capital Reinvestment Ratio (2014–2025)

This chart tracks CU Medical Systems Inc's Capital Reinvestment Ratio across 10 annual periods. For the full cash flow conversion analysis, see CU Medical Systems Inc operating cash flow efficiency.

Annual Capital Reinvestment Ratio for CU Medical Systems Inc (2014–2025)

Year-by-year Capital Reinvestment Ratio for CU Medical Systems Inc from 2014 to 2025. See CU Medical Systems Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (KRW) Capital Expenditures YoY Change
2025 0.08x ₩9.69 Billion ₩776.17 Million ▼ -94.4%
2024 1.43x ₩14.07 Billion ₩20.06 Billion ▲ +82.3%
2023 0.78x ₩8.28 Billion ₩6.47 Billion ▼ -79.0%
2022 3.72x ₩3.12 Billion ₩11.60 Billion ▼ -64.8%
2021 10.58x ₩490.43 Million ₩5.19 Billion ▲ +6845.8%
2020 0.15x ₩8.41 Billion ₩1.28 Billion ▼ -98.7%
2018 11.73x ₩3.12 Billion ₩36.56 Billion ▲ +213176.2%
2017 0.01x ₩6.96 Billion ₩38.27 Million ▼ -98.4%
2015 0.34x ₩3.51 Billion ₩1.19 Billion ▼ -80.8%
2014 1.76x ₩551.48 Million ₩970.94 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow